serw-MX  [xml]  

 DeCS Categories

A06 Endocrine System .
A06.407 Endocrine Glands .
C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.490 Paraneoplastic Endocrine Syndromes .
C04.730 Paraneoplastic Syndromes .
C04.730.713 Paraneoplastic Endocrine Syndromes .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.473 Paraneoplastic Endocrine Syndromes .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.472 Hormones .
D06.472.445 Invertebrate Hormones .
D06.472.445.573 Insect Hormones .
D06.472.699 Peptide Hormones .
D06.472.699.327 Hypothalamic Hormones .
D06.472.699.327.700 Pituitary Hormone Release Inhibiting Hormones .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.400 Neuropeptides .
D12.644.400.400 Hypothalamic Hormones .
D12.644.400.400.700 Pituitary Hormone Release Inhibiting Hormones .
D12.644.548 Peptide Hormones .
D12.644.548.365 Hypothalamic Hormones .
D12.644.548.365.700 Pituitary Hormone Release Inhibiting Hormones .
D12.776 Proteins .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.650 Neuropeptides .
D12.776.631.650.405 Hypothalamic Hormones .
D12.776.631.650.405.700 Pituitary Hormone Release Inhibiting Hormones .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.353 Endocrine Disruptors .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.472 Hormones .
D27.888 Toxic Actions .
D27.888.141 Endocrine Disruptors .
E02 Therapeutics .
E02.319 Drug Therapy .
E02.319.452 Hormone Replacement Therapy .
G04 Cell Physiological Phenomena .
G04.085 Cell Communication .
G04.085.100 Autocrine Communication .
 Synonyms & Historicals
Hormone Antagonists .
Antagonists, Hormone .
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. .
Endocrine Disruptors .
Endocrine Disruptor Effect .
Endocrine Disruptor Effects .
Chemicals, Endocrine Disrupting .
Disruptor Effect, Endocrine .
Disruptor Effects, Endocrine .
Disruptors, Endocrine .
Effect, Endocrine Disruptor .
Effects, Endocrine Disruptor .
Endocrine Disrupting Chemicals .
Exogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism. .
Endocrine Glands .
Endocrine Gland .
Gland, Endocrine .
Ductless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body. .
Hormones .
Hormone .
Hormone Receptor Agonists .
Agonists, Hormone Receptor .
Receptor Agonists, Hormone .
Hormones, Synthetic .
Hormone Analogs .
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. .
Insect Hormones .
Hormones, Insect .
Hormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones. .
Autocrine Communication .
Autocrine Communications .
Autocrine Signalings .
Communication, Autocrine .
Communications, Autocrine .
Signaling, Autocrine .
Signalings, Autocrine .
Autocrine Signaling .
Mode of communication wherein a bound hormone affects the function of the cell type that produced the hormone. .
Pituitary Hormone Release Inhibiting Hormones .
Gonadostatin .
Pituitary Hormone-Release Inhibiting Hormones .
Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Used for PHRIH in general or for which there is no specific heading. .
Hormone Replacement Therapy .
Therapy, Hormone Replacement .
Hormone Replacement Therapies .
Replacement Therapies, Hormone .
Therapies, Hormone Replacement .
Replacement Therapy, Hormone .
Therapeutic use of hormones to alleviate the effects of hormone deficiency. .
Paraneoplastic Endocrine Syndromes .
Ectopic Hormone Syndrome .
Endocrine Syndrome, Paraneoplastic .
Paraneoplastic Endocrine Syndrome .
Syndrome, Ectopic Hormone .
Syndrome, Paraneoplastic Endocrine .
Syndromes, Ectopic Hormone .
Syndromes, Paraneoplastic Endocrine .
Ectopic Hormone Syndromes .
Neoplastic Endocrine-Like Syndromes .
Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion. .